Group 1 - Southbound funds increased their holdings in Alibaba Health (00241.HK) by 3.354 million shares on November 26, 2025, marking a 0.19% change [1][2] - Over the past five trading days, southbound funds have increased their holdings for four days, with a total net increase of 6.738 million shares [1] - In the last 20 trading days, there have been 13 days of net increases, totaling 44.136 million shares [1] Group 2 - As of now, southbound funds hold 1.784 billion shares of Alibaba Health, accounting for 11.02% of the company's total issued ordinary shares [1] - The company primarily engages in the sale of pharmaceutical health products and operates e-commerce platforms for pharmaceuticals and consumer healthcare services [2] - Alibaba Health is a flagship platform for Alibaba Group in the health sector, utilizing cloud computing and big data technologies for digital healthcare and internet medical services [2]

Group 1 - The core point of the article highlights the recent reduction in holdings of Alibaba Health (00241.HK) by southbound funds, with a total net reduction of 15.94 million shares over the last five trading days and 35.13 million shares over the last 20 trading days [1][2] - As of now, southbound funds hold 1.736 billion shares of Alibaba Health, accounting for 10.76% of the company's total issued ordinary shares [1][2] - The daily changes in shareholdings show a consistent trend of reduction, with the most recent decrease being 316,000 shares on October 27, 2025, representing a change of -0.02% [2] Group 2 - Alibaba Health Information Technology Co., Ltd. is a holding company providing industrial internet solutions for the healthcare and pharmaceutical industry, serving as Alibaba's flagship platform in the health sector [2] - The company primarily engages in the sales of pharmaceutical health products, operates e-commerce platforms for pharmaceuticals, and offers consumer healthcare services, leveraging technologies such as cloud computing and big data [2]